These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 7655324)

  • 1. Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women's Health Study.
    Gapstur SM; Potter JD; Drinkard C; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):313-8. PubMed ID: 7655324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there?
    Potter JD; Cerhan JR; Sellers TA; McGovern PG; Drinkard C; Kushi LR; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):319-26. PubMed ID: 7655325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol consumption and breast cancer risk in the Women's Health Study.
    Zhang SM; Lee IM; Manson JE; Cook NR; Willett WC; Buring JE
    Am J Epidemiol; 2007 Mar; 165(6):667-76. PubMed ID: 17204515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.
    Bardia A; Hartmann LC; Vachon CM; Vierkant RA; Wang AH; Olson JE; Sellers TA; Cerhan JR
    Arch Intern Med; 2006 Dec 11-25; 166(22):2478-83. PubMed ID: 17159013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women.
    Sellers TA; Vierkant RA; Cerhan JR; Gapstur SM; Vachon CM; Olson JE; Pankratz VS; Kushi LH; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1104-7. PubMed ID: 12376515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol and breast cancer risk defined by estrogen and progesterone receptor status: a case-control study.
    Deandrea S; Talamini R; Foschi R; Montella M; Dal Maso L; Falcini F; La Vecchia C; Franceschi S; Negri E
    Cancer Epidemiol Biomarkers Prev; 2008 Aug; 17(8):2025-8. PubMed ID: 18708394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for hormone receptor-defined breast cancer in postmenopausal women.
    Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unopposed estrogen therapy and the risk of invasive breast cancer.
    Chen WY; Manson JE; Hankinson SE; Rosner B; Holmes MD; Willett WC; Colditz GA
    Arch Intern Med; 2006 May; 166(9):1027-32. PubMed ID: 16682578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term meat intake and risk of breast cancer by oestrogen and progesterone receptor status in a cohort of Swedish women.
    Larsson SC; Bergkvist L; Wolk A
    Eur J Cancer; 2009 Nov; 45(17):3042-6. PubMed ID: 19464165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.
    Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk factors according to joint estrogen receptor and progesterone receptor status.
    Rusiecki JA; Holford TR; Zahm SH; Zheng T
    Cancer Detect Prev; 2005; 29(5):419-26. PubMed ID: 16185815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States).
    Li CI; Malone KE; Daling JR
    Cancer Causes Control; 2006 Jun; 17(5):695-703. PubMed ID: 16633917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate intake and risk of breast cancer characterized by hormone receptor status.
    Zhang SM; Hankinson SE; Hunter DJ; Giovannucci EL; Colditz GA; Willett WC
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):2004-8. PubMed ID: 16103452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies.
    Ma H; Bernstein L; Pike MC; Ursin G
    Breast Cancer Res; 2006; 8(4):R43. PubMed ID: 16859501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and progesterone receptor status in breast cancer: effect of oral contraceptive pills and hormone replacement therapy.
    Tewari M; Pradhan S; Singh U; Shukla HS
    Breast; 2007 Oct; 16(5):540-5. PubMed ID: 17587581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status.
    Zhang M; Yang H; Holman CD
    Breast Cancer Res Treat; 2009 Dec; 118(3):553-63. PubMed ID: 19252980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
    Nichols HB; Trentham-Dietz A; Love RR; Hampton JM; Hoang Anh PT; Allred DC; Mohsin SK; Newcomb PA
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.